Results of CRS and Debulking in PMP Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01427101
Recruitment Status : Unknown
Verified August 2011 by Uppsala University.
Recruitment status was:  Active, not recruiting
First Posted : September 1, 2011
Last Update Posted : September 1, 2011
Information provided by (Responsible Party):
Uppsala University

Brief Summary:
The aim of this study was to compare debulking surgery and cytoreductive surgery in patients with Pseudomyxoma Peritonei with respect to efficacy and safety.

Condition or disease
Pseudomyxoma Peritonei

Study Type : Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Comparison Between Cyotreductive Surgery and Debulking Surgery in Patients With Pseudomyxoma Peritonei
Study Start Date : September 1993

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. Overall survival
    from treatment and forward

Secondary Outcome Measures :
  1. morbidity and mortality [ Time Frame: 90 days ]
    mortality is messured during the first 90 postoperative days and morbidity during hospital stay.

Biospecimen Description:
Patients treated from 1993 are included and during these years treatment strategy has changed. The different strategies are compared but its juts one cohort of patients. No completion date are set due to that reports from other centres show that there are longtime survivers in both treatment groups.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   20 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with Pseudomyxoma Peritonei, sceduled for surgical treatment at Uppsala University Hospital.

Inclusion Criteria:

  • Patients with radiology histopathology finding of Pseudomyxoma Peritonei

Exclusion Criteria:

  • Preformance status WHO >2 and histopathology shows other origin then Pseudomyxoma Peritonei

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01427101

Sponsors and Collaborators
Uppsala University
Principal Investigator: Haile Mahteme, MD, PhD Uppsala University

Responsible Party: Uppsala University Identifier: NCT01427101     History of Changes
Other Study ID Numbers: 2007/073-PMP-Andréasson
First Posted: September 1, 2011    Key Record Dates
Last Update Posted: September 1, 2011
Last Verified: August 2011

Keywords provided by Uppsala University:
Pseudomyxoma Peritonei
Cytoreductive surgery
Debulking surgery
Intraperitoneal chemotherapy

Additional relevant MeSH terms:
Pseudomyxoma Peritonei
Neoplasms, Cystic, Mucinous, and Serous
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type